Drugs Made In America Acquisition Corp (DMAAU)株価、チャート、ニュース、およびAI分析

Q: Drugs Made In America Acquisition Corp のCEOは誰ですか？

Ms. Lynn Stockwell は Drugs Made In America Acquisition Corp の Executive Chairman of the Board で、2024 から在籍しています。

Q: DMAAU の株価パフォーマンスは？

DMAAU の現在の価格は $10.55 で、最終取引日から 0% 減少 変動しました。

Q: Drugs Made In America Acquisition Corp の主な事業テーマや業界は？

Drugs Made In America Acquisition Corp は N/A 業界、セクターは N/A に属しています。

Q: Drugs Made In America Acquisition Corp の時価総額はいくらですか？

Drugs Made In America Acquisition Corp の現在の時価総額は $353.6M です。

ホーム

株式

DMAAU

DMAAU Price

Drugs Made In America Acquisition Corp

$10.55

終値： Feb 06, 16:00:00 GMT-5

$10.55

アフターマーケット：Feb 06, 20:00:00 GMT-5

概要予測収入配当財務状況

主要データ

前終値

$10.55

始値

$10.55

当日レンジ

$10.55 - $10.55

52週レンジ

$10 - $10.82

取引高

平均取引高

5.6K

1株当たり利益(TTM)

0.20

配当利回り

時価総額

$353.6M

DMAAUとは何ですか？

Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.

特徴

取引戦略